PLOS Currents is an innovative, online publication channel for new scientific research and ideas organized by focused research areas. It aims to minimize the delay between the generation and publication of new research, and publishes content which is peer-reviewed; citable; publicly archived in PubMed; and indexed by Scopus.PLOS Currents removes barriers to communication and exchange in the following ways:
A single, integrated direct-authoring and publishing platform Have complete control over the formatting and appearance of your published work.
Open and flexible article format and structure to best suit research and increase ease of submission Publish your negative results, single figures or experiments, research in progress, protocols, datasets, etc.
Streamlined peer review process that determines as rapidly as possible if the conception, structure and presentation of the submission indicate that it is a legitimate work of science and does not contain any obvious methodological, ethical or legal violations. Emphasis is placed on the results and data, rather than on perceived impact Have your submission reviewed in a matter of days and published immediately after editorial acceptance.
Targeted publishing within a defined research community to that research results proliferate in a focused manner, thereby enhancing interaction and advancing innovation Reach the right people.
Browse articles and submit your research today. To contact PLOS Currents, please email firstname.lastname@example.org.
Huntington Disease (produced with support from CHDI Foundation) considers all aspects of research into Huntington disease. Topics include (but are not limited to) molecular and cell biology; genetics and genomics; animal models; behavioural, translational and clinical research.
Muscular Dystrophy (produced with support from Parent Project Muscular Dystrophy) considers submissions relevant specifically to Duchenne Muscular Dystrophy and other muscular dystrophies. Topics include molecular and cell biology; genetics and genomics; animal models; behavioural, translational and clinical research; pathogenetic mechanisms; and experimental therapeutics.
Disasters considers any content relevant to disasters—natural or manmade, local, regional or global. Possible topics include: description of disasters; effects of disasters on the environment or on human populations; immediate management of disasters, both environmental and clinical; disaster risk management; disaster risk reduction; follow up of disasters, short and long term; implementation of the Hyogo Framework for Action 2005-2015. Specific article types may include case studies, surveys, or other research (clinical, environmental, etc.) of previous or ongoing disasters; analyses and evaluation of operational responses and management of disasters; and protocols for response to disasters.
Outbreaks considers research in all aspects of infectious disease outbreaks, including respiratory pathogens as well as foodborne and travel-related outbreaks. The editors welcome research relevant to any infectious disease outbreak with impact or potential impact on human health, including but not restricted to the following: influenza, salmonella, haemorrhagic fever, norovirus, Ebola, coronavirus, meningitis, E. coli, zoonotic and vector-borne infections, health care-acquired infections. Prior to expanding the scope PLOS Currents: Outbreaks limited submissions to influenza research. The PLOS Currents: Influenza archives are available here.
Tree of Life is a venue for the publication of phylogenetic research that informs our understanding of organismal evolution. The Editors welcome submissions which describe analyses that provide support for existing relationships; large-scale analyses that provide an overview of many taxa, or a novel algorithm for estimating phylogenies; reports on new or novel insights to relationships; and synthetic papers on groups, particularly enigmatic groups (e.g., retroviruses).
Evidence on Genomic Tests takes a broad of the definition of genomic testing. Suitable topics include many proteomic testing schemes and protein-based tests (although tests for single biomarkers or antigens are generally not suitable), and applications that are termed “genetic tests”. Authors may wish to consult the definition of genetic testing provided on page 17 of the 2008 SACGHS report US System of Oversight of Genetic Testing: A Response to the Charge of the Secretary of Health and Human Services. One potential source of topics is the Genomic Applications for Practice and Prevention Knowledge Base (GAPPKB).